146.68 Grant for colposcopies and other services.
146.71 Determination of death.
146.81 Health care records; definitions.
146.815 Contents of certain patient health care records.
146.816 Uses and disclosures of protected health information.
146.817 Preservation of fetal monitor tracings and microfilm copies.
146.819 Preservation or destruction of patient health care records.
146.82 Confidentiality of patient health care records.
146.83 Access to patient health care records.
146.835 Parents denied physical placement rights.
146.84 Violations related to patient health care records.
146.87 Federal registration numbers for prescribers of controlled substances.
146.89 Volunteer health care provider program.
146.903 Disclosures required of health care providers and hospitals.
146.905 Reduction in fees prohibited.
146.91 Long-term care insurance.
146.95 Patient visitation.
146.96 Uniform claim processing form.
146.997 Health care worker protection.
146.001
146.001
Definitions. In this chapter unless the context otherwise requires:
146.001(1)
(1) “Department" means the department of health services.
146.001(2)
(2) “Secretary" means the secretary of health services.
146.0255
146.0255
Testing infants for controlled substances or controlled substance analogs. 146.0255(2)
(2) Testing. Any hospital employee who provides health care, social worker, or intake worker under ch.
48 may refer an infant or an expectant mother of an unborn child, as defined in s.
48.02 (19), to a physician for testing of the bodily fluids of the infant or expectant mother for controlled substances or controlled substance analogs if the hospital employee who provides health care, social worker, or intake worker suspects that the infant or expectant mother has controlled substances or controlled substance analogs in the bodily fluids of the infant or expectant mother because of the use of controlled substances or controlled substance analogs by the mother while she was pregnant with the infant or by the expectant mother while she is pregnant with the unborn child. The physician may test the infant or expectant mother to ascertain whether or not the infant or expectant mother has controlled substances or controlled substance analogs in the bodily fluids of the infant or expectant mother, if the physician determines that there is a serious risk that there are controlled substances or controlled substance analogs in the bodily fluids of the infant or expectant mother because of the use of controlled substances or controlled substance analogs by the mother while she was pregnant with the infant or by the expectant mother while she is pregnant with the unborn child and that the health of the infant, the unborn child or the child when born may be adversely affected by the controlled substances or controlled substance analogs. If the results of the test indicate that the infant does have controlled substances or controlled substance analogs in the infant's bodily fluids, the physician shall report the occurrence of that condition in the infant to the agency, as defined in s.
48.981 (1) (ag), that is responsible for conducting child abuse and neglect investigations under s.
48.981, and that agency shall offer to provide, or arrange or refer for the provision of, services and treatment for the child and the child's mother as provided under s.
46.238. If the results of the test indicate that the expectant mother does have controlled substances or controlled substance analogs in the expectant mother's bodily fluids, the physician may report the occurrence of that condition in the expectant mother to the agency, as defined in s.
48.981 (1) (ag), that is responsible for conducting unborn child abuse investigations under s.
48.981, and that agency shall offer to provide, or arrange or refer for the provision of, services and treatment for the unborn child and expectant mother as provided under s.
46.238. Under this subsection, no physician may test an expectant mother without first receiving her informed consent to the testing.
146.0255(3)
(3) Test results. The physician who performs a test under sub.
(2) shall provide the infant's parents or guardian or the expectant mother with all of the following information:
146.0255(3)(a)
(a) A statement of explanation concerning the test that was performed, the date of performance of the test and the test results.
146.0255(3)(b)
(b) A statement of explanation that the test results of an infant must, and that the test results of an expectant mother may, be disclosed to an agency under sub.
(2) if the test results are positive.
146.0255(4)
(4) Confidentiality. The results of a test given under this section may be disclosed as provided in sub.
(3).
146.0257
146.0257
Evaluation of infants for fetal alcohol spectrum disorders. 146.0257(2)
(2) Evaluation. If a hospital employee who provides health care, social worker, or intake worker under ch.
48 suspects that an infant has a fetal alcohol spectrum disorder, the hospital employee, social worker, or intake worker shall refer the infant to a physician for an evaluation to diagnose whether the infant has that disorder. If a physician determines that there is a serious risk that an infant has a fetal alcohol spectrum disorder, the physician shall evaluate the infant to diagnose whether the infant has that disorder. If a physician diagnoses that an infant has a fetal alcohol spectrum disorder, the physician shall report that diagnosis to the agency that is responsible for conducting child abuse and neglect investigations under s.
48.981, and that agency shall offer to provide, or arrange or refer for the provision of, services and treatment for the infant and the infant's mother as provided under s.
46.238.
146.0257(3)
(3) Diagnosis. A physician who performs an evaluation under sub.
(2) shall provide the infant's parents or guardian with all of the following information:
146.0257(3)(a)
(a) An explanation concerning the evaluation that was performed, the date of that evaluation, and the diagnosis resulting from that evaluation.
146.0257(3)(b)
(b) An explanation that the results of the evaluation must be disclosed to an agency under sub.
(2) if the evaluation indicates a diagnosis of a fetal alcohol spectrum disorder.
146.0257(4)
(4) Confidentiality. The results of an evaluation performed under sub.
(2) may be disclosed as provided in sub.
(3).
146.0257 History
History: 2013 a. 260.
146.085
146.085
Pay toilets prohibited. 146.085(1)(1)
Prohibition. The owner or manager of any public building shall not permit an admission fee to be charged for the use of any toilet compartment.
146.085(2)
(2) Penalty. Any person who violates this section shall be fined not less than $10 nor more than $50.
146.085(3)
(3) Enforcement. The department, the department of safety and professional services, and the public service commission shall enforce this section within their respective jurisdictions.
146.15
146.15
Information. State officials, physicians of mining, manufacturing and other companies or associations, officers and agents of a company incorporated by or transacting business under the laws of this state, shall when requested furnish, so far as practicable, the department any information required touching the public health; and for refusal shall forfeit $10.
146.16
146.16
Expenses. Expenses incurred under this chapter, not made otherwise chargeable, shall be paid by the town, city or village.
146.17
146.17
Limitations. Nothing in the statutes shall be construed to authorize interference with the individual's right to select his or her own physician or mode of treatment, nor as a limitation upon the municipality to enact measures in aid of health administration, consistent with statute and acts of the department.
146.17 History
History: 1993 a. 482.
146.22
146.22
Flushing devices for urinals. The department shall not promulgate any rules which either directly or indirectly prohibit the use of manual flushing devices for urinals. The department shall take steps to encourage the use of manual flushing devices for urinals.
146.22 History
History: 1977 c. 418.
146.25
146.25
Required implanting of microchip prohibited. 146.25(1)(1)
No person may require an individual to undergo the implanting of a microchip.
146.25(2)
(2) Any person who violates sub.
(1) may be required to forfeit not more than $10,000. Each day of continued violation constitutes a separate offense.
146.25 History
History: 2005 a. 482.
146.29
146.29
Access to toilet facility in retail establishment. 146.29(1)(a)
(a) “Eligible medical condition" means inflammatory bowel disease, irritable bowel syndrome, or any other medical condition that periodically requires immediate access to a toilet facility.
146.29(1)(b)
(b) “Inflammatory bowel disease" means Crohn's disease or ulcerative colitis.
146.29(1)(c)
(c) “Ostomy device" means a medical device that creates an artificial passage for elimination of body waste.
146.29(1)(e)
(e) “Retail establishment" means a store or shop in which retail sales is the principal business conducted, except that “retail establishment" does not include a motor vehicle fuel retailer's establishment that is a structure that is 800 square feet or less in size.
146.29(2)
(2) Access to toilet facility required. A retail establishment that has a toilet facility that is designated for use by the establishment's employees shall permit a person who suffers from an eligible medical condition or uses an ostomy device to use the toilet facility if all of the following apply:
146.29(2)(a)
(a) The person provides the retail establishment any of the following:
146.29(2)(a)1.
1. A copy of a written statement, signed and issued by a physician on the physician's letterhead or that of the facility with which the physician is associated, that indicates that the person suffers from an eligible medical condition or uses an ostomy device.
146.29(2)(a)2.
2. An identification card issued by an entity approved by the department under sub.
(4) that indicates that the person suffers from an eligible medical condition or uses an ostomy device.
146.29(2)(b)
(b) The person requests to use the toilet facility during the retail establishment's usual business hours.
146.29(2)(c)
(c) Three or more employees of the retail establishment are working at the establishment at the time the person requests use of the toilet facility.
146.29(2)(d)
(d) The toilet facility is not located in an area where access creates an obvious health or safety risk for the person or an obvious security risk for the retail establishment.
146.29(2)(e)
(e) The retail establishment does not have a toilet facility that the public may use.
146.29(2)(f)
(f) A public toilet facility is not immediately accessible to the person.
146.29(3)
(3) Limitation on requirement. No retail establishment may, under this section, be required to make physical changes to a toilet facility that is designated for use by the establishment's employees.
146.29(4)
(4) Entities that may issue identification cards. The department shall approve, to issue identification cards that may be used under sub.
(2) (a) 2., entities that provide services to, or advocate on behalf of, persons who suffer from an eligible medical condition or use an ostomy device.
146.29(5)(a)
(a) Whoever violates sub.
(2) may be required to forfeit not more than $200.
146.29(5)(b)
(b) Whoever does any of the following with respect to a written statement or identification card that is specified in sub.
(2) (a) may be required to forfeit not more than $200:
146.29(5)(b)1.
1. Forges a statement or identification card, or utters a forged statement or identification card.
146.29(5)(b)2.
2. Alters a statement or identification card, or utters an altered statement or identification card.
146.29(5)(b)3.
3. Transfers to another person, for use by that person, a statement or identification card intended for use by a different person.
146.29(5)(b)4.
4. Knowingly possesses a forged or altered statement or identification card.
146.29(5)(c)
(c) Each day of continued violation under par.
(a) or
(b) constitutes a separate offense.
146.29 History
History: 2009 a. 198.
146.31
146.31
Blood or tissue transfer services. 146.31(1)(1)
It is unlawful to operate a blood bank for commercial profit.
146.31(2)
(2) The procurement, processing, distribution or use of whole blood, plasma, blood products, blood derivatives and other human tissues such as corneas, bones or organs for the purpose of injecting, transfusing or transplanting any of them into the human body is declared to be, for all purposes except as provided under s.
146.345, the rendition of a service by every person participating therein and, whether or not any remuneration is paid therefor, not to be a sale of the whole blood, plasma, blood products, blood derivatives or other tissues. No person involved in the procurement, processing, distribution or use of whole blood, plasma, blood products or blood derivatives for the purpose of injecting or transfusing any of them into the human body shall be liable for damages resulting from these activities except for his or her own negligence or willful misconduct.
